U.S. flag An official website of the United States government
  1. Home
  2. Drugs
  3. DDT COA #000061: Plexiform Neurofibroma Impact in Children & Adults
  1. Drugs

DDT COA #000061: Plexiform Neurofibroma Impact in Children & Adults

Clinical Outcome Assessments (COA) Qualification Submissions
Office of Hematology and Oncology Products (OHOP)
Division of Oncology Products 2 (DOP 2)

DDT COA Number
DDT COA #000061

Instrument Name
Plexiform Neurofibroma Pain Impact in Children & Adults

Disease/Condition
Plexiform neurofibroma (PN)

Concept of Interest
Tumor-related pain intensity, pain interference, and physical functioning

Context of Use
Children (>5 years) and adults with neurofibromatosis type 1 (NF1) and PN

COA Type
PRO

Qualification Stage
In transition to 507 process 

Requestor(s)
Pam Wolters

Contact(s)
Pam Wolters

Date Accepted into CDER’s COA Qualification Program
March 6, 2014

Back to Clinical Outcome Assessments (COA) Qualification Submission